GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Total Assets

Bide Pharmatech Co (SHSE:688073) Total Assets : ¥2,352 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co Total Assets?

Bide Pharmatech Co's Total Assets for the quarter that ended in Sep. 2024 was ¥2,352 Mil.

During the past 12 months, Bide Pharmatech Co's average Total Assets Growth Rate was -3.20% per year. During the past 3 years, the average Total Assets Growth Rate was 42.10% per year. During the past 5 years, the average Total Assets Growth Rate was 54.50% per year.

During the past 6 years, Bide Pharmatech Co's highest 3-Year average Total Assets Growth Rate was 73.30%. The lowest was 42.10%. And the median was 56.50%.

Total Assets is connected with ROA %. Bide Pharmatech Co's annualized ROA % for the quarter that ended in Sep. 2024 was 5.49%. Total Assets is also linked to Revenue through Asset Turnover. Bide Pharmatech Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.12.

Bide Pharmatech Co Total Assets Historical Data

The historical data trend for Bide Pharmatech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bide Pharmatech Co Total Assets Chart

Bide Pharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 265.53 531.90 906.13 2,359.21 2,415.03

Bide Pharmatech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,414.26 2,415.03 2,381.92 2,314.15 2,352.17

Bide Pharmatech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Bide Pharmatech Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=2089.542+325.486
=2,415

Bide Pharmatech Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=1997.973+354.192
=2,352

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bide Pharmatech Co  (SHSE:688073) Total Assets Explanation

Total Assets is connected with ROA %.

Bide Pharmatech Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=128.06/( (2314.147+2352.165)/ 2 )
=128.06/2333.156
=5.49 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Bide Pharmatech Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=279.171/( (2314.147+2352.165)/ 2 )
=279.171/2333.156
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Bide Pharmatech Co Total Assets Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bide Pharmatech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Total Assets
Comparable Companies
SHSE:688566 SZSE:300194 SHSE:600488 SZSE:300485 SZSE:002728 SZSE:300401 SHSE:688247 SHSE:603520 SZSE:002437 SZSE:300110 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433
Website
https://www.bidepharmatech.com
Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.
Executives
Dai Lan Director

Bide Pharmatech Co Headlines

No Headlines